Buenaflor Industries, a company offering a maintenance drug for hypertension is currently evaluating on penetrating the Philippine market. Based on the market research conducted by the company, there are three existing potential competitors with the following total production per unit for the past 5 years. Year Green Star Pascu Laboratories Uni Pharmaceutical 2015 2,350,000 2,783,000 2,935,000 2016 2,375,000 2,834,000 2,935,000 2017 2,450,000 2,850,000 2,935,000 2018 2,475,000 2,850,000 2,935,000 2019 2,500,000 2,832,000 2,935,000 According to the Philippine Council for Health Research and Development (PCHRD) 21% of Filipino adults are hypertensive. Below is the historical population of adult Filipinos for the past 5 years. Year Historical Population 2015 59,143,200 2016 60,572,900 2017 62,016,100 2018 63,473,100 2019 64,944,000

Using the arithmetic straight line method, determine the projected demand for the next five years (2020-2024).

Using the arithmetic geometric curve, determine the projected supply for the next five years (2020-2024).